|
US2011236917A1
|
|
Diagnosis of Alzheimer's Disease
|
|
US2010004871A1
|
|
Identities, specificities, and use of twenty two (22) differentially expressed protein biomarkers for blood based diagnosis of breast cancer
|
|
US2010129846A1
|
|
Isoform specificities of blood serum proteins and their use as differentially expressed protein biomarkers for diagnosis of breast cancer
|
|
US2010167937A1
|
|
Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum
|
|
US2009061457A1
|
|
Apolipoprotein E3 protein as a biomarker of Parkinson's disease
|
|
US2009275046A1
|
|
Complement factor H protein as a biomarker of Parkinson's disease
|
|
US2009035801A1
|
|
Twelve (12) protein biomarkers for diagnosis and early detection of breast cancer
|
|
US2007017809A1
|
|
Assay for ALS and ALS-like disorders
|
|
US2006278532A1
|
|
Assay for neuromuscular diseases
|
|
US2006014301A1
|
|
Antibody-based system for detection of differential protein expression patterns
|
|
US2006068452A1
|
|
Differential protein expression patterns related to disease states
|
|
US2006115867A1
|
|
TRIM 5 related protein as a biomarker of neurodegenerative disease
|
|
US2006115854A1
|
|
Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease
|
|
US2006115856A1
|
|
2'-5'-oligoadenylate synthetase like protein as a biomarker for neurodegenerative disease
|
|
US2006115855A1
|
|
FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease
|
|
US2006046276A1
|
|
Acetyl-LDL receptor as a biomarker for breast cancer
|
